{"entity":{"type":"insider","cik":"0001682323","url":"/insider/0001682323","json_url":"/insider/0001682323.json","name":"Albright Charles","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":13,"first":"2018-05-25","last":"2020-12-17","span_basis":"filed_date"},"name_variants":[{"name":"Albright Charles","source":"filing","n_filings":13,"first_seen":"2018-05-25","last_seen":"2020-12-17"}],"transactions":[{"id":2973917,"accession":"0001179110-20-012070","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-20-012070","line_url":"/filing/0001179110-20-012070","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":63.21564,"price_display":"63.22","price_state":"stated","total_value":632156.4,"total_display":"632,156.40","total_whole":"632,156","shares_owned_after":29131.0,"shares_owned_after_display":"29,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider","n_lines":3},{"id":3337282,"accession":"0001179110-20-011830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-011830","line_url":"/filing/0001179110-20-011830#line-2","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":24907.0,"shares_owned_after_display":"24,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-09","filed_date":"2020-12-11","scope":"insider"},{"id":2973843,"accession":"0001179110-20-011752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-011752","line_url":"/filing/0001179110-20-011752#line-2","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":800400.0,"total_display":"800,400.00","total_whole":"800,400","shares_owned_after":24907.0,"shares_owned_after_display":"24,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-08","scope":"insider"},{"id":2432128,"accession":"0001179110-20-010963","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-010963","line_url":"/filing/0001179110-20-010963#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":228.0,"shares_display":"228","price_per_share":31.21,"price_display":"31.21","price_state":"stated","total_value":7115.88,"total_display":"7,115.88","total_whole":"7,116","shares_owned_after":24907.0,"shares_owned_after_display":"24,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider"},{"id":2870579,"accession":"0001179110-20-010507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-010507","line_url":"/filing/0001179110-20-010507#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.39,"price_display":"31.39","price_state":"stated","total_value":94170.0,"total_display":"94,170.00","total_whole":"94,170","shares_owned_after":25135.0,"shares_owned_after_display":"25,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider"},{"id":2184522,"accession":"0001179110-20-009170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009170","line_url":"/filing/0001179110-20-009170#line-2","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.29,"price_display":"35.29","price_state":"stated","total_value":352900.0,"total_display":"352,900.00","total_whole":"352,900","shares_owned_after":28135.0,"shares_owned_after_display":"28,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":2114372,"accession":"0001179110-20-008833","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-008833","line_url":"/filing/0001179110-20-008833#line-3","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238.0,"shares_display":"238","price_per_share":34.99,"price_display":"34.99","price_state":"stated","total_value":8327.62,"total_display":"8,327.62","total_whole":"8,328","shares_owned_after":28135.0,"shares_owned_after_display":"28,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-10","scope":"insider"},{"id":2114370,"accession":"0001179110-20-008833","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008833","line_url":"/filing/0001179110-20-008833#line-2","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":37.47,"price_display":"37.47","price_state":"stated","total_value":374700.0,"total_display":"374,700.00","total_whole":"374,700","shares_owned_after":28373.0,"shares_owned_after_display":"28,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-06","filed_date":"2020-08-10","scope":"insider"},{"id":3186816,"accession":"0001179110-20-008367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-008367","line_url":"/filing/0001179110-20-008367#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":32.22,"price_display":"32.22","price_state":"stated","total_value":96660.0,"total_display":"96,660.00","total_whole":"96,660","shares_owned_after":28373.0,"shares_owned_after_display":"28,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider"},{"id":2651172,"accession":"0001179110-20-005605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-005605","line_url":"/filing/0001179110-20-005605#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (EVP/Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP/Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP/Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":151.0,"shares_display":"151","price_per_share":25.28,"price_display":"25.28","price_state":"stated","total_value":3817.28,"total_display":"3,817.28","total_whole":"3,817","shares_owned_after":31373.0,"shares_owned_after_display":"31,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-08","scope":"insider"},{"id":2064023,"accession":"0001179110-20-001370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-001370","line_url":"/filing/0001179110-20-001370#line-2","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":622.0,"shares_display":"622","price_per_share":26.95,"price_display":"26.95","price_state":"stated","total_value":16762.9,"total_display":"16,762.90","total_whole":"16,763","shares_owned_after":31524.0,"shares_owned_after_display":"31,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-10","scope":"insider"},{"id":2150333,"accession":"0001179110-20-001026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-001026","line_url":"/filing/0001179110-20-001026#line-2","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5549.0,"shares_display":"5,549","price_per_share":26.5431,"price_display":"26.54","price_state":"stated","total_value":147287.6619,"total_display":"147,287.66","total_whole":"147,288","shares_owned_after":20553.0,"shares_owned_after_display":"20,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider"},{"id":6594940,"accession":"0001179110-18-008611","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-008611","line_url":"/filing/0001179110-18-008611#line-2","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.98,"price_display":"35.98","price_state":"stated","total_value":359800.0,"total_display":"359,800.00","total_whole":"359,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-13","filed_date":"2018-06-15","scope":"insider"},{"id":6446681,"accession":"0001179110-18-007566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-007566","line_url":"/filing/0001179110-18-007566#line-2","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001682323","owner_name":"Albright Charles","owner_display_name":"Albright Charles","owner_url":"/insider/0001682323","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001650664","name":"Editas Medicine, Inc.","url":"/issuer/0001650664","role":"Officer (EVP/Chief Scientific Officer)","n_filings":13,"first_seen":"2018-05-25","last_seen":"2020-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001682323","retrieved_at":"2026-08-24T23:38:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}